Statements (58)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:Company
|
gptkbp:bfsLayer |
4
|
gptkbp:bfsParent |
gptkb:Zydus_Cadila
|
gptkbp:acquisition |
Liva Healthcare
Mylan's non-US generics business |
gptkbp:category |
gptkb:skincare_product
animal health products prescription medications nutraceuticals OTC products |
gptkbp:clinical_trial |
conducts clinical trials globally
|
gptkbp:collaborations |
academic institutions
research organizations |
gptkbp:community_engagement |
supports local communities
promotes health awareness provides healthcare access |
gptkbp:employees |
over 25,000
|
gptkbp:founded |
gptkb:1995
|
gptkbp:founder |
gptkb:Pankaj_R._Patel
|
gptkbp:headquarters |
gptkb:Ahmedabad,_India
|
https://www.w3.org/2000/01/rdf-schema#label |
Zydus Group
|
gptkbp:industry |
Pharmaceuticals
|
gptkbp:invention |
holds numerous patents
|
gptkbp:investment |
in biotechnology
in biosimilars in digital health in vaccine development |
gptkbp:leadership |
Dr. R. S. Sharma is the Chief Scientific Officer
Pankaj R. Patel is the Chairman Sharvil Patel is the Managing Director |
gptkbp:market |
global
over 100 countries |
gptkbp:partnership |
gptkb:Bristol-Myers_Squibb
gptkb:Gilead_Sciences with government for health programs |
gptkbp:products |
generic drugs
vaccines biologics |
gptkbp:rank |
among top 50 pharmaceutical companies
|
gptkbp:regulatory_compliance |
gptkb:FDA
gptkb:WHO gptkb:EMA |
gptkbp:research |
Dr. Sharvil Patel
|
gptkbp:research_and_development |
focus on oncology
focus on infectious diseases focus on chronic diseases focus on cardiovascular diseases focus on diabetes |
gptkbp:revenue |
over $2 billion
|
gptkbp:social_responsibility |
environmental initiatives
education initiatives healthcare initiatives |
gptkbp:subsidiary |
gptkb:Zydus_Cadila
|
gptkbp:sustainability_initiatives |
water conservation programs
renewable energy usage reducing carbon footprint waste management initiatives |
gptkbp:website |
www.zyduscadila.com
|